20.500.12556/DiRROS-28819 A non-coding signature in SHROOM3 is associated with kidney disease progression in Fabry disease Fabry disease is a rare, X-linked lysosomal storage disorder that often leads to progressive kidney dysfunction. Despite carrying the same pathogenic GLA variant, patients exhibit considerable variability in the onset and progression of Fabry nephropathy, suggesting the involvement of additional genetic modifiers. This study aimed to investigate the possible role of genetic polymorphisms in non-coding regions. A total of 284 patients with Fabry disease were included in the study and divided into two groups based on the progression of the kidney disease. Ten selected single nucleotide polymorphisms located in non-coding regions of podocyterelated genes were analyzed using quantitative PCR with TaqMan probes. The analysis revealed significant associations between specific genotypes and an increased risk of rapid progression of Fabry nephropathy. In particular, the rs9992101 and rs17319721 polymorphisms in the SHROOM3 gene were significantly associated with higher odds of accelerated kidney function decline. However, neither of these polymorphisms nor the polygenic risk scores were associated with conventional biomarkers of kidney disease. Our results suggest that non-coding genetic variants in podocyte-related genes may contribute to the phenotypic variability observed in Fabry nephropathy. The integration of such genetic biomarkers into clinical practice could improve early risk stratification, support more individualized patient monitoring, and facilitate therapeutic decision-making. Fabry disease nephrophaty non-coding variants podocytes single nucleotide polymorphisms Fabrijeva bolezen nekodirajoče spremembe podociti genetski modifikatorji polimorfizem posameznega nukleotida true false true Angleški jezik Slovenski jezik Neznano 2026-04-08 12:49:33 2026-04-08 12:49:34 2026-04-09 03:51:21 0000-00-00 00:00:00 2026 0 0 Nasl. z nasl. zaslona; Opis vira z dne 5. 1. 2026; str. 1-9 iss. 1, [Article no.] 109710 Vol. 147 Jan. 2026 0000-00-00 Zaloznikova Objavljeno NiDoloceno 0000-00-00 0000-00-00 0000-00-00 61:577.2 1096-7206 10.1016/j.ymgme.2025.109710 263408387 RAZ_Levstek_Tina_2026.pdf RAZ_Levstek_Tina_2026.pdf 1 F874078576D83DF80B7611D02D0B50F3 f46179e21b9652fb4f2aca5e930b9d4de1ee89124ab51e14e7ca80749854396b cc326474-3338-11f1-b941-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=42938 https://www.sciencedirect.com/science/article/pii/S1096719225007024?via%3Dihub 1 a2d1166e-3338-11f1-b941-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=42937 Univerzitetni klinični center Ljubljana 0 0 0